Status:
COMPLETED
Comparative Study Between Hormonal and Hysteroscopic Management of Cesarean Scar Defect
Lead Sponsor:
Alexandria University
Conditions:
Cesarean Scar Defect
Eligibility:
FEMALE
25-42 years
Phase:
NA
Brief Summary
Up to 70% of women who have had a previous caesarean section experience uterine niche, with 30% having symptoms. Prevalence rates vary between 24-70% using transvaginal ultrasonography and 56-84% usin...
Detailed Description
The study include 78 women diagnosed with abnormal uterine bleeding (AUB). All cases were subjected for complete history taking, complete general and gynaecological examination, vaginal ultrasonograph...
Eligibility Criteria
Inclusion
- women with age ranging from 25 to 42 years,
- previous cesarean section,
- presence of a cesarean scar defect on ultrasound with a residual myo3metrium of \> 1.5 mm.
Exclusion
- any contraindications of hysteroscopy as an active pelvic infection, active genital herpes,
- Contraindications to hormonal treatment as medical conditions like breast cancer, history of deep venous thrombosis, Previous arterial thrombosis, pulmonary embolism, active liver disease, use of rifampicin, familial hyperlipidemia, pregnancy,
- patient refusal
- Any Other causes of abnormal uterine bleeding as polyp, adenomyosis. leiomyoma, malignancy, coagulopathy. and ovulatory disorders.
Key Trial Info
Start Date :
February 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2023
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT06529952
Start Date
February 10 2022
End Date
February 20 2023
Last Update
July 31 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
El shatby hospital Alexandria university
Alexandria, Egypt
2
Tamer
Alexandria, Egypt